Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
ALBANY, New York, October 10, 2013 /PRNewswire/ --
New Report Added in ResearchMoz Reports Database Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth
ResearchMoz announces that it has published a new study Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth
Researchmoz presents this most up-to-date Market Research Reports on Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth
(http://www.researchmoz.us/asthma-therapeutics-market-to-2019-breakthrough-biologics-to-enhance-treatment-of-severe-asthma-and-drive-market-growth-report.html). The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Asthma Therapeutics Market.
A leading business intelligence provider, has released its latest research report "Asthma Market to 2019". The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This growth is expected despite the generic erosion facing the leading brands, and is a consequence of new market entrants and a disease prevalence that continues to rise, albeit not at rates as high as have been seen in the past. Some new, costly asthma therapies could be set to enter the asthma market, including GlaxoSmithKline's (GSK's) recently approved Relvar (fluticasone/vilanterol), and multiple monoclonal antibodies (mAbs).
These include reslizumab, mepolizumab and lebrikizumab, which are being developed by Teva, GSK and Roche respectively. The mAbs, in particular, have the potential to change the asthma treatment landscape, most notably with regards to severe forms of the disease. Although such therapy may only play the role of an alternative treatment in the asthma treatment algorithm, their ability to reduce exacerbation rates has strong clinical and commercial value.
To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/asthma-therapeutics-market-to-2019-breakthrough-biologics-to-enhance-treatment-of-severe-asthma-and-drive-market-growth-report.html
The report assesses the current asthma market, and forecasts market trends to 2019, analyzing key drivers and barriers. The areas covered include the following:
A disease introduction, which defines the disease, including symptoms, diagnosis and treatment
Analysis of the landscape of the asthma market, including a comparison of the efficacy and safety of the most prominent brands
Detailed analysis of the asthma pipeline, including, among other parameters, details of drug distribution by phase, molecule type and mechanism of action. The asthma clinical trial landscape is then analyzed, with a particular emphasis on failure rates across phases as well as trends in clinical trial size and duration, and by mechanism of action. This section also includes single-product forecasts for the most promising pipeline drugs.
An in-depth forecasting model for the asthma market, which considers the current marketed therapies, in addition to the potential market entry of new products. The model consists of a projected outcome, with high and low variance results, depending on the potential performance of pipeline therapies.
Analysis of strategic consolidations within the asthma indication, including co-development and licensing agreements
An overview of the drivers and barriers for the asthma market
Browse More Report @ http://www.researchmoz.us/therapeutic-area-market-reports-37.html
Reasons to Buy
Primarily, the report will enable clients to establish a strong understanding of the asthma indication, helping to identify and understand market opportunities and the emerging competitive environment. It will also enable you to:
Understand the asthma pipeline and the factors that indicate that it is becoming more innovative. This is highlighted by the presence of numerous biologics in the pipeline, which look set to have a major impact upon the asthma market.
Observe detailed profiles for promising pipeline products, including revenue forecasts, and gain insights into how they are likely to compete in the market and who their main competitors will be.
Follow the trends in asthma clinical trial size and duration in relation to industry averages. In addition, the report will enable you to assess the potential risk of future developmental programs for asthma therapeutics, depending on the mechanism of action, by considering the recorded clinical trial failure rates.
Observe the potential growth patterns expected for the asthma market over the forecast period, and identify which countries are expected to contribute the most to this growth.
Table of Content
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Disease Introduction
2.6 Assessment of Disease Severity
2.8 Treatment Algorithm
3 Marketed Products
3.1 Product Profiles
3.1.1 Advair Diskus (fluticasone and salmeterol) - GlaxoSmithKline
3.1.2 Symbicort (budesonide/formoterol) - AstraZeneca, Co-promotion with Astellas Pharma Inc
3.1.3 Singulair (montelukast) - Merck & Co
3.1.4 Xolair (omalizumab) - Novartis and Genentech
3.1.5 Foradil (formoterol) - Novartis (Co-marketed by Novartis and Schering Corporation)
3.1.6 Dulera/Zenhale (mometasone/formoterol) - Merck & Co
3.1.7 Relvar/Breo - GlaxoSmithKline/Theravance
4 Asthma Pipeline
4.2 Mechanisms of Action in the Pipeline
4.3 Clinical Trials
4.3.1 Failure Rate
4.3.2 Clinical Trial Duration
4.3.3 Clinical Trial Size
4.3.4 Comparative Clinical Trial Metrics Analysis
4.4 Promising Pipeline Molecules
4.4.1 Reslizumab - Teva Pharmaceutical ltd
4.4.2 Mepolizumab - GlaxoSmithKline
4.4.3 Lebrikizumab - Roche/Genentech
4.4.4 Veramyst - GlaxoSmithKline
4.4.5 Andolast - Rottapharm Madaus
4.4.6 Spiriva (Tiotropium Bromide) - Boehringer Ingelheim
4.5 Heat Map of Safety and Efficacy for Pipeline and Marketed Products
5 Market Forecast to 2019
5.1 Geographical Markets
5.1.1 Global Market
5.1.2 North America
5.1.3 Top Five Countries of Europe
5.2 Drivers and Barriers for the Asthma Therapeutics Market
6 Strategic Consolidations
6.1 Major Licensing Deals
6.2 Major Co-development Deals
7.1 All Pipeline Drugs by Phase
7.1.3 Phase I
7.1.4 Phase II
7.1.5 Phase III
7.2 Market Forecast to 2019
7.3.1 References for Pipeline Heat Map
7.3.2 References for Marketed Heat Map
7.4 Market Definitions
7.8 Secondary Research
7.9 Therapeutic Landscape
7.10 Epidemiology-Based Forecasting
7.10.1 Analogous Forecasting Methodology
7.11 Market Size by Geography
7.11.1 Forecasting Model for Therapeutic Areas
7.12 Geographical Landscape
7.13 Pipeline Analysis
7.14 Competitive Landscape
7.14.1 Expert Panel Validation
7.15 Contact Us
New Research Reports:
Big Data and Telecom Analytics Market: Big Data refers to a massive volume of both structured and unstructured data that is so large that it is difficult to process using traditional database and software techniques. While the presence of such datasets is not something new, the past few years have witnessed immense commercial investments in solutions that address the processing and analysis of Big Data. Big Data opens a vast array of applications and opportunities in multiple vertical sectors including, but not limited to, retail and hospitality, media, utilities, financial services, healthcare and pharmaceutical, telecommunications, government, homeland security, and the emerging industrial Internet vertical. To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/big-data-and-telecom-analytics-market-business-case-market-analysis-and-forecasts-2014-2019-report.html
Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection looks at the market, competitive landscape, and trends for the two mammography equipment market segments: digital radiography mammography equipment and film-screen mammography equipment. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important Merger and Acquisition (M&A) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/mammography-equipment-market-to-2019-growth-driven-by-technical-advances-in-digital-radiography-that-enhance-workflow-and-improve-breast-cancer-detection-report.html
Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019
New Market Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things. According to Susan Eustis, lead author of the study, "Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution."
To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/wireless-infrastructure-market-shares-strategies-and-forecasts-worldwide-2013-to-2019-report.html
Business Intelligence & Analytics Market in India 2013: The Business Intelligence & Analytics Market in India is part of Netscribes' IT & ITeS Series reports. Advent of smartphones and tablets along with rising adoption in key sectors such as BFSI, Healthcare, Retail etc. will have a favorable impact on the Indian Business Intelligence & Analytics Market. The report begins with an overview of the major macroeconomic indicators which highlights the present economic scenario prevalent in India. It is followed by an introduction section which provides a typical architectural model of Business Intelligence (BI). It also shows the value proposition by BI & Analytics. It further describes types of Business Intelligence available in the market. The market overview section provides a brief snapshot of the BI & Analytics market in India. It shows the market size and growth of the market in India. Further it shows segmentation of the market by SMBs and non-SMBs in 2012. It also provides industry vertical wise split of BI usage in the country. This section further highlights the market leads in BI & Analytics market in India. To Browse Full TOC, Tables & Figures visit:http://www.researchmoz.us/business-intelligence-and-analytics-market-in-india-2013-report.html
Global SMB Web Analytics Market 2012-2016: Analysts forecast the Global SMB Web Analytics market to grow at a CAGR of 16.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to enhance marketing activities. The Global SMB Web Analytics market has also been witnessing the increasing demand for mobile analytics. However, the lack of skilled personnel could pose a challenge to the growth of this market.The Global SMB Web Analytics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global SMB Web Analytics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/global-smb-web-analytics-market-2012-2016-report.html
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
90 Sate Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-997-4948
©2012 PR Newswire. All Rights Reserved.